148 related articles for article (PubMed ID: 7787967)
1. Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked immunosorbent assay in patients with liver diseases.
Watanabe Y; Mori S; Fujiyama S; Sato T; Mori M
Enzyme Protein; 1994-1995; 48(1):18-26. PubMed ID: 7787967
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.
Ohnishi M; Higuchi A; Matsumura H; Arakawa Y; Nakamura H; Nirei K; Yamamoto T; Yamagami H; Ogawa M; Gotoda T; Matsuoka S; Nakajima N; Sugitani M; Moriyama M; Murayama H
Int J Med Sci; 2017; 14(7):629-638. PubMed ID: 28824294
[No Abstract] [Full Text] [Related]
3. Investigation of ornithine carbamoyltransferase as a biomarker of liver cirrhosis.
Matsushita N; Hashimoto E; Tokushige K; Kodama K; Tobari M; Kogiso T; Torii N; Taniai M; Shiratori K; Murayama H
Intern Med; 2014; 53(12):1249-57. PubMed ID: 24930642
[TBL] [Abstract][Full Text] [Related]
4. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
Murayama H; Fukuda Y; Tsunekawa S; Ikemoto M; Nagata A
Clin Biochem; 2007 Sep; 40(13-14):1077-80. PubMed ID: 17570354
[TBL] [Abstract][Full Text] [Related]
5. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
6. A sensitive enzyme-linked immunosorbent assay of serum ornithine carbamoyltransferase.
Watanabe Y; Mori S; Ozaki M; Fujiyama S; Sato T; Mori M
Enzyme Protein; 1994-1995; 48(1):10-7. PubMed ID: 7787966
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
Miyake S
Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
[TBL] [Abstract][Full Text] [Related]
8. Superiority of serum type-I arginase and ornithine carbamyltransferase in the detection of toxicant-induced acute hepatic injury in rats.
Murayama H; Ikemoto M; Fukuda Y; Nagata A
Clin Chim Acta; 2008 May; 391(1-2):31-5. PubMed ID: 18279670
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of serum guanase activity in liver diseases.
Nishikawa Y; Fukumoto K; Watanabe F
Clin Biochem; 1984 Oct; 17(5):327-30. PubMed ID: 6499163
[TBL] [Abstract][Full Text] [Related]
10. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.
Williams AL; Hoofnagle JH
Gastroenterology; 1988 Sep; 95(3):734-9. PubMed ID: 3135226
[TBL] [Abstract][Full Text] [Related]
11. Advantage of serum type-I arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats.
Murayama H; Ikemoto M; Fukuda Y; Tsunekawa S; Nagata A
Clin Chim Acta; 2007 Jan; 375(1-2):63-8. PubMed ID: 16872590
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of an enzymic profile for the differential diagnosis of viral hepatitis.
Plomteux G
Clin Chem; 1980 Dec; 26(13):1897-9. PubMed ID: 7438442
[TBL] [Abstract][Full Text] [Related]
13. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Park GJ; Lin BP; Ngu MC; Jones DB; Katelaris PH
J Gastroenterol Hepatol; 2000 Apr; 15(4):386-90. PubMed ID: 10824882
[TBL] [Abstract][Full Text] [Related]
14. A sensitive ELISA for serum ornithine carbamoyltransferase utilizing the enhancement of immunoreactivity at alkaline pH.
Murayama H; Igarashi M; Mori M; Fukuda Y; Ikemoto M; Nagata A
Clin Chim Acta; 2006 Jun; 368(1-2):125-30. PubMed ID: 16445902
[TBL] [Abstract][Full Text] [Related]
15. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
[TBL] [Abstract][Full Text] [Related]
16. [The diagnostic value of glutamic acid dehydrogenase].
Rettenbacher-Däubner H; Rieder H; Sburny I
Acta Hepatosplenol; 1967; 14(4):209-21. PubMed ID: 4297959
[No Abstract] [Full Text] [Related]
17. Clinical significance of serum guanase activity in various liver diseases.
Shiota G; Fukada J; Ito T; Tsukizawa M; Yamada M; Sato M
Jpn J Med; 1989; 28(1):22-4. PubMed ID: 2542677
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome localized human hepatic alanine-glyoxylate aminotransferase and its application to clinical diagnosis.
Nakatani T; Kawasaki Y; Minatogawa Y; Okuno E; Kido R
Clin Biochem; 1985 Oct; 18(5):311-6. PubMed ID: 4053344
[TBL] [Abstract][Full Text] [Related]
19. Review of pyridoxal phosphate and the transaminases in liver disease.
Vanderlinde RE
Ann Clin Lab Sci; 1986; 16(2):79-93. PubMed ID: 3008634
[TBL] [Abstract][Full Text] [Related]
20. Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells.
Murayama H; Ikemoto M; Fukuda Y; Tsunekawa S; Nagata A
Clin Chim Acta; 2007 May; 380(1-2):170-4. PubMed ID: 17350606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
